(1 - 12 from 26
)
AC Immune and Lilly Announce License and Collaboration ...ir.acimmune.com › news-releases › news-release-details
ir.acimmune.com
... disease, including amyloid plaques and tau tangles," said Mark Mintun , M.D., vice president of neurodegeneration and pain research at Lilly.
FDA accepts Lilly's protocol of pain trial for CID initiativewww.clinicaltrialsarena.com › news › lilly-pain-trial-pr...
www.clinicaltrialsarena.com
Lilly pain and neurodegeneration research vice-president Mark Mintun said: “Real solutions will depend on a holistic transformation in the way ...
Lilly Announces Positive Phase 3 Results in Study of Flortaucipir PET ...
investor.lilly.com
"These encouraging results are a major advance in our ability to image the pathology of Alzheimer's disease," said Mark Mintun , M.D., vice ...
Lilly Reception LabCentral | Cambridge, MA
labcentral.org
LabCentral is a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups.
sorted by relevance / date